# Sumitomo Dainippon Pharma Co., Ltd., Suzuka, Japan – FDA Inspections

Source: https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612

> Inspection records and compliance data for Sumitomo Dainippon Pharma Co., Ltd. in Suzuka. 6 FDA inspections on record, 1 Form 483, last inspected August 07, 2025.

---

## Details

- Name: Sumitomo Dainippon Pharma Co., Ltd.
- FEI Number: 3003028650
- Address Line 1: 1450, Yasuzuka-Cho
- City: Suzuka
- Country Name: Japan
- Address: 1450, Yasuzuka-Cho, Suzuka, Japan
- Country: Japan

## Related Documents

- [483 - Sumitomo Dainippon Pharma Co., Ltd. - 2025-08-07](https://www.keypedia.com/records/483/sumitomo-dainippon-pharma-co-ltd/86bec48e-adb4-4655-bc52-1a8046463dde) — source: FDA, date: August 7, 2025
- [FDA Inspection 1277764 - Sumitomo Dainippon Pharma Co., Ltd. - 2025-08-07](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/43625239-cfee-4173-8772-0af3efdf143c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 7, 2025
- [483 - Sumitomo Dainippon Pharma Co., Ltd. - 2019-11-22](https://www.keypedia.com/records/483/sumitomo-dainippon-pharma-co-ltd/1731dc44-1562-4b56-a1ab-11523c1ef33a) — source: FDA, date: November 22, 2019
- [FDA Inspection 1113228 - Sumitomo Dainippon Pharma Co., Ltd. - 2019-11-22](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/1c86b0d4-989e-4cae-ad7f-4339b52c4cd9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2019
- FDA Inspection 1064584 - Sumitomo Dainippon Pharma Co., Ltd. - 2018-07-27 — classification: No Action Indicated (NAI), source: FDA, date: July 27, 2018
- FDA Inspection 990466 - Sumitomo Dainippon Pharma Co., Ltd. - 2016-09-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 9, 2016
- FDA Inspection 853865 - Sumitomo Dainippon Pharma Co., Ltd. - 2013-11-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 1, 2013
- FDA Inspection 770009 - Sumitomo Dainippon Pharma Co., Ltd. - 2012-02-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 23, 2012
- FDA Inspection 770009 - Sumitomo Dainippon Pharma Co., Ltd. - 2012-02-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 23, 2012

## Related Companies

- [Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany](https://www.keypedia.com/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [Patheon Pharmaceuticals Inc.](https://www.keypedia.com/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b)
- [Cohance Lifesciences Limited](https://www.keypedia.com/companies/cohance-lifesciences-limited/c01306bf-33dc-4f28-a424-11cda764a0d5)
- [Amgen, Inc.](https://www.keypedia.com/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8)
- [FUJIFILM Diosynth Biotechnologies Denmark ApS](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-denmark-aps/513b3c42-1517-43bc-936a-d3edd26bed70)
- [Boehringer Ingelheim Pharma GmbH & Co. KG](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263)
- [Eli Lilly & Company](https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)

## Related Officers

- [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [ Drug Investigator](https://www.keypedia.com/people/tekalign-wondimu/3b80e5c8-4062-4e1d-8ddd-b1afa2616dec)
